Global DNA & RNA Banking Services Market is valued approximately USD 5.77 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.46 % over the forecast period 2020-2027. DNA & RNA Banking Services Market is a type of bio repository that stores Human samples for research like genomics and medicines. Also, the DNA & RNA Banking Services Market is used for treating diseases and illness that need immediate care. The increasing investments in urgent care, increasing geriatric population, increasing cancer cases globally and strategic development between hospitals and urgent care providers has led the adoption of DNA & RNA Banking Services Market across the forecast period. For Instance: as per the National Cancer Institute of USA the annual rate of new cancer cases is 442.4 per 100,000 men and women (based on cases from 2013 to 2017). Based on 20132017 deaths, the cancer mortality is 158.3 per 100,000 men and women per year. However, high infrastructure development costs impedes the growth of the market over the forecast period of 2020-2027. Also, (Opportunity) with the increasing prevalence of cancer cases, the adoption & demand for DNA & RNA Banking Services Market is likely to increase the market growth during the forecast period.

The regional analysis of global DNA & RNA Banking Services Market market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Europe is the leading region across the world in terms of market share owing to the growing geriatric population and promptness & affordability of urgent care services coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest CAGR over the forecast period 2020-2027. Factors such as reduced cost of research & development, is one of the major factors to create lucrative growth prospects for the DNA & RNA Banking Services Market market across Asia-Pacific region.

Major market player included in this report are:

EasyDNA
Thermo Fisher Scientific, Inc
OraSure Technologies, Inc.
23andMe, Inc.
GoodCell
ProteoGenex, Inc.
US Biolab Corporation, Inc.
Infinity Biologix LLP
Amgen Inc
Brooks Life Sciences

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

Transportation Service
Processing Service
Storage Service
Quality Control Service
Data Storage
Others

By Specimen Type
Blood
Buccal Swabs & Hair Follicles
Others

By Application

Therapeutics
Drug Discovery & Clinical Research
Clinical Diagnostics
Other Applications

By End-use

Academic Research
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year 2017, 2018
Base year 2019
Forecast period 2020 to 2027

Target Audience of the Global DNA & RNA Banking Services Market Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors